Neuro-Innovators Revenue

Biotechnology Research • Sewickley Heights, Pennsylvania, United States • 1-10 Employees

Neuro-Innovators revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,000,000
Total funding	No funding

Key Contact at Neuro-Innovators

Howison Schroeder

Co-Founder & Chief Executive Officer

Company overview

Headquarters	Sewickley Heights, Pennsylvania, United States
Website	neuro-innovators.com
NAICS	541714
Keywords	Stroke, Neuroscience, Stroke Rehabilitation, Neuropharmacology, Neuroplasticity, Neuro-Rehabilitation
Founded	2021
Employees	1-10

Neuro-Innovators Email Formats

Neuro-Innovators uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@neuro-innovators.com), used 66.7% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@neuro-innovators.com	66.7%
{first name}.{last name}	john.doe@neuro-innovators.com	33.3%

About Neuro-Innovators

Neuro-Innovators, Inc. Healing Brains with Neuroplastic Medicine™ About Us Neuro-Innovators (NIV) is a clinical-stage, first-in-class biopharmaceutical company pioneering neuroplastic medicine—therapies that unlock the brain’s innate ability to rewire, rebuild, and recover after injury or disease. Our Approach Traditional single-molecule drugs have consistently failed in neurology: too slow, too costly, too narrow in mechanism. We are changing the paradigm through a de-risked polypharmacology strategy: Engineered Combinations of FDA-approved drugs reformulated into a single oral capsule to act on multiple neuroplasticity pathways simultaneously. Accelerated Development using the FDA’s 505(b)(2) pathway, lowering risk, cost, and time to market. Lead Program NIV-001 is being developed to reduce chronic motor disability in the 7 million U.S. stroke survivors. Backed by FDA-accepted objective functional outcome metrics, NIV-001 offers lower regulatory risk, reduced trial costs, and faster timelines. Stroke recovery alone represents a $20B+ U.S. market opportunity. Future Pipeline Our platform extends beyond stroke recovery to other neurologic conditions, including: Dementia & cognitive decline Parkinson’s & movement disorders Traumatic Brain Injury (TBI) Our Mission We are redefining neuro-recovery medicine and building a new category of neuroplastic therapeutics to transform outcomes for millions of patients worldwide. 📩 Interested in partnering, investing, or collaborating? Connect with us or reach out at h.schroeder@neuro-innovators.com

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Entry

Founder/Owner

Employees by Department

Neuro-Innovators has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

Neuro-Innovators has never raised funding before.

Frequently asked questions

Neuro-Innovators is located in Sewickley Heights, Pennsylvania, US.

Neuro-Innovators generates an estimated annual revenue of $598,885. This revenue figure reflects the company's market position and business performance in its industry.

Neuro-Innovators has an estimated valuation of $2,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Neuro-Innovators was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Neuro-Innovators has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Neuro-Innovators

Howison Schroeder

Co-Founder & Chief Executive Officer

4.8

40,000 users